Navigation Links
Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
Date:2/23/2011

an be used to selectively completely or partially reverse the anticoagulant effect of pegnivacogin.  REG1, presently in a phase 2b clinical trial (the RADAR trial), is intended for application in arterial thrombosis applications, initially in Acute Coronary Syndrome patients intended for Percutaneous Coronary Intervention.  A clinical program in Open Heart Surgery [including coronary artery bypass grafting (CABG) and valve repair/replacement] is also under development.  REG2, Regado's second product candidate, consists of a subcutaneously administered depot formulation of pegnivacogin paired with the IV bolus formulation of anivamersen.  REG2 recently completed single escalating dose phase 1 clinical testing (the first successful subcutaneous application of an aptamer in humans) and is planned to be studied in a multiple escalating dose clinical trial in 2011.  It is intended for use in venous thrombosis indications such as venous thromboembolism (VTE) prophylaxis in patients undergoing abdominal surgery.  REG3, Regado's third program, consists of a specific GPVI inhibitor and its active control agent (RB571 and RB515, respectively).  REG3 is planned to enter phase 1 human clinical testing in 2011 and will be indicated for antiplatelet therapy.  Information pertaining to Regado's clinical programs may be obtained at www.clinicaltrials.gov.

ABOUT APTAMERS

Pegnivacogin is a member of a class of compounds called aptamers.  Aptamers are single stranded oligonucleotides that adopt a specific conformation enabling direct, specific inhibition of the targeted protein.   A key unique feature of aptamers derives from the fact that they are formed from nucleic acids.  As such, their pharmacologic activity can be controlled by a matched, complementary oligonucleotide active control agent (the Watson-Crick base pair complement of a fraction of the agent to be control
'/>"/>

SOURCE Regado Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
6. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
7. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
8. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
9. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
10. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
11. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014  Wearable sports and activity ... less than two years, producing a massive amount ... huge opportunity exists for leveraging this data to ... ) introduced a first-of-its-kind wearable analytics platform for ... of clinical research linking activity and health risks, ...
(Date:9/16/2014)... Sept. 16, 2014  Relmada Therapeutics, Inc., (OTCBB: RLMD), ... of chronic pain, announced today that it has entered ... (MSKCC) in a series of animal studies for levorphanol, ... extended release form of levorphanol.  Gavril Pasternak, MD, PhD, ... Dr. Pasternak said, "Levorphanol is a ...
(Date:9/16/2014)... 2014 Henry Schein, Inc. (NASDAQ: ... health care products and services to office-based dental, ... Stanley M. Bergman, Henry Schein,s Chairman of the Board and ... services panel at the Leerink Partners Services Roundtable on Tuesday, ... Dr. Stohler, Dean of Columbia University,s College of ...
Breaking Medicine Technology:Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 2Doctors Launch Initiative to Bridge Gap Between Wearables and Meaningful Health Data 3Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3Henry Schein To Present At The Leerink Partners Services Roundtable 2
(Date:9/16/2014)... York, NY (PRWEB) September 16, 2014 After ... program as one of the premier fertility centers in the ... Paul Gindoff have returned to their hometown of New York ... with Chelsea IVF and Genetics Labs. , Chelsea Fertility ... of becoming a parent in the New York Tri-State Area, ...
(Date:9/16/2014)... New York, NY (PRWEB) September 16, 2014 ... they are actually hungry, but for comfort during times ... consist of fatty, sugar laden treats that may provide ... as well as sabotaging the best laid weight loss ... Diet Plans that provide patients with the skills ...
(Date:9/16/2014)... YELM, Washington (PRWEB) September 16, 2014 ... to attend the Capstone Event in Yelm, Washington, Oct. ... event finishes the year and caps off the remarkable ... around the world in Switzerland, Italy, Australia, South Korea, ... is $1000, half price for children ages 6-19 and ...
(Date:9/16/2014)... 2014 With Pfister Energy Inc as ... Antonio, TX. has been awarded a solar technology contract ... US, including Alaska and Hawaii, U.S. Territories and the ... (EITF) and the Corps of Engineers, Engineering and Support ... to fund renewable and alternative energy projects greater than ...
(Date:9/16/2014)... 2014 Dr. Randy Carlson and ... the Love Your Marriage event is coming to ... helping married couples to better communicate, increase intimacy and have ... evening of fun, encouragement and learning to strengthen your marriage ... 26 – Living Word Bible Church (Mesa), Saturday, Sept. 27 ...
Breaking Medicine News(10 mins):Health News:Chelsea Fertility NYC Offers New and Affordable Fertility Treatment Options for Patients in the New York Tri-State Area 2Health News:Chelsea Fertility NYC Offers New and Affordable Fertility Treatment Options for Patients in the New York Tri-State Area 3Health News:Chelsea Fertility NYC Offers New and Affordable Fertility Treatment Options for Patients in the New York Tri-State Area 4Health News:Diet Doc Announces Emotional Eaters Diet Plans to Help Patients Break the Cycle for Fast and Permanent Weight Loss 2Health News:Diet Doc Announces Emotional Eaters Diet Plans to Help Patients Break the Cycle for Fast and Permanent Weight Loss 3Health News:Ramtha School Presents Capstone Event in Yelm Oct. 20-26 2Health News:Solar Construction Opportunity at U.S Army Installations Awarded to Pfister Energy & Infinity Development 2Health News:The Intentional Living Center Introduces the Love Your Marriage Night Featuring Dr. Randy Carlson in Arizona 2
... number of Australian HIV cases in the past seven years ... in men having sex with men, and some clear geographic ... research published online for the Medical Journal of Australia. ... at the National Centre in HIV Epidemiology and Clinical Research ...
... of quitting smoking, but are prepared to try and lessen ... ,However, after studying healthcare literature, a team of Cochrane ... to this alternative of cutting down the number of cigarettes. ... has been at helping them to stop smoking completely. But, ...
... Researchers have revealed that combining a non-pyrethroid insecticide, ... to be an effective insecticide-repellent synergy against ... ,A combination of the two had proved ... addition of their respective properties. Mosquito nets soaked ...
... Research Foundation (MDRF), in collaboration with the U.K.-based Oxford ... Centre in Chennai . ,For the people ... products, this is a significant development. For now scientific ... Index (the metabolic speed at which food is converted ...
... a sensible diet, exercise and weight control helps people ... Howard Hughes Medical Institute have found that all these ... pathway in the brain. ,This insulin-like pathway ... body. The pathway is activated when insulin and insulin-like ...
... linked bipolar disorder or manic depression with accelerated shrinking of ... condition defined as recurrent episodes of significant disturbance in moods. ... researchers led by Dr. Andrew McIntosh at the University of ... the grey matter in the brain of people with bipolar ...
Cached Medicine News:Health News:HIV Cases Increasing In Australia 2Health News:Chain Smokers Prepared to Lessen Their Daily Cigs Rather Than Quitting 2Health News:Insecticide and Repellent Combo Effective in Eliminating Malarial Mosquitoes 2Health News:A Centre for Glycemic Index Testing Opened in Chennai 2Health News:Sensible Diet, Exercise and Weight Control Increases Longevity 2Health News:Sensible Diet, Exercise and Weight Control Increases Longevity 3
... The Veris physiological monitor offers a comprehensive ... specifically designed for pediatric and neonate patients, ... to 3T. Veris is the first MR ... of pediatric and neonate patient monitoring. The ...
The SonoSite MicroMaxx gives you big machine performance in a lightweight package. This laptop-sized, durable unit represents the technology crossover point between hand-carried ultrasound and larger...
The IDS Gamma-B 25-Hydroxy Vitamin D kit is a conventional liquid phase radioimmunoassay intended for the quantitative determination of 25-hydroxy vitamin D (25-OHD) and other hydroxylated metabolite...
... is a fully automated ... for clotting, photometric and ... tests.The medium-throughput analyser offers ... tubes, 45 reagents onboard, ...
Medicine Products: